Asian equity markets experienced widespread declines on Friday, closely following significant losses on Wall Street. Concurrently, global oil prices maintained a precarious position near the critical $100 per barrel threshold, as escalating anxieties over the ongoing Iran war continued to fuel fears about potential disruptions to crude oil and natural gas supplies.
Market Performance Across Asia
Japan's benchmark Nikkei 225 index retreated by 1.1%, closing at 53,867.74 points. Technology-focused stocks were among the hardest hit, with SoftBank Group witnessing a substantial decline of 4.5%. In South Korea, the Kospi index fell 1.3% to settle at 5,511.83.
Hong Kong's Hang Seng index recorded a marginal loss of 0.1%, finishing the session at 25,680.65. Conversely, mainland China's Shanghai Composite index managed a slight gain of 0.1%, closing at 4,131.44. Australia's S&P/ASX 200 edged up 0.1% to 8,639.60, while Taiwan's Taiex index traded 0.7% lower.
Oil Market Volatility and Geopolitical Tensions
Oil prices demonstrated relative stability in early Friday trading, yet remained highly sensitive to geopolitical developments. The international benchmark, Brent crude, advanced 0.6% to $97.22 per barrel. This follows a recent surge where it breached the $100 mark on Thursday, having earlier in the week approached $120 per barrel. Meanwhile, the U.S. benchmark, West Texas Intermediate crude, experienced a slight dip of 0.2%, trading at $95.22 per barrel.
The primary driver of market unease stems from heightened tensions in the Middle East. In his inaugural public address, Iran's new Supreme Leader, Ayatollah Mojtaba Khamenei, vowed that Iran would persist in its military efforts and continue to leverage control over the Strait of Hormuz. This critical maritime chokepoint, responsible for an estimated 20% of global oil shipments, has seen significant disruptions to marine traffic, effectively constricting flows.
Analysts at Mizuho Bank highlighted in a commentary that attacks on vessels in and around the strait have intensified concerns regarding "the scale of supply disruption and persistent shipping bottlenecks." These remarks from Iran's leadership followed statements by U.S. President Donald Trump, who described the war as "very complete," further amplifying worries about the potential duration of the conflict.
Broader Economic Implications
The volatility in oil markets has been pronounced since the onset of the Iran conflict, with Brent crude reaching its highest levels since 2022 earlier this week. In response to supply fears, the International Energy Agency announced on Wednesday that its member nations would release a record 400 million barrels from their strategic petroleum reserves. However, many economists remain skeptical, suggesting this intervention may provide only limited reassurance to jittery markets.
The surge in energy prices carries significant inflationary risks for the global economy. Rising fuel costs are already beginning to impact consumers worldwide and could potentially increase production expenses across various sectors. Some analysts warn that escalating energy prices might, for instance, elevate costs associated with artificial intelligence development and semiconductor manufacturing.
Wall Street Sets a Negative Tone
U.S. stock markets set a somber precedent for Asian trading, recording substantial losses on Thursday amidst a month characterized by erratic swings. The S&P 500 index dropped 1.5% to 6,672.62, the Dow Jones Industrial Average fell 1.6% to 46,677.85, and the Nasdaq composite declined 1.8% to 22,311.98.
Companies with significant exposure to fuel expenses endured particularly sharp declines. Cruise-ship operator Carnival plummeted 7.9%, and United Airlines sank 4.6%, underscoring the direct impact of energy costs on corporate profitability.
In early Friday currency trading, the U.S. dollar strengthened slightly against the Japanese yen, rising to 159.35 yen from 159.34. The euro remained virtually unchanged at $1.1511. U.S. stock futures, however, offered a glimmer of optimism, advancing 0.4% in early indications.
